- Home
- RAPT vs MGF Comparison
RAPT vs MGF Comparison
Compare RAPT & MGF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- MGF
- Stock Information
- Founded
- RAPT 2015
- MGF 1987
- Country
- RAPT United States
- MGF United States
- Employees
- RAPT N/A
- MGF N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- MGF Trusts Except Educational Religious and Charitable
- Sector
- RAPT Health Care
- MGF Finance
- Exchange
- RAPT Nasdaq
- MGF Nasdaq
- Market Cap
- RAPT 117.5M
- MGF 100.1M
- IPO Year
- RAPT 2019
- MGF N/A
- Fundamental
- Price
- RAPT $7.35
- MGF $3.07
- Analyst Decision
- RAPT Buy
- MGF
- Analyst Count
- RAPT 5
- MGF 0
- Target Price
- RAPT $42.00
- MGF N/A
- AVG Volume (30 Days)
- RAPT 120.8K
- MGF 104.4K
- Earning Date
- RAPT 08-07-2025
- MGF 01-01-0001
- Dividend Yield
- RAPT N/A
- MGF 7.64%
- EPS Growth
- RAPT N/A
- MGF N/A
- EPS
- RAPT N/A
- MGF N/A
- Revenue
- RAPT N/A
- MGF N/A
- Revenue This Year
- RAPT N/A
- MGF N/A
- Revenue Next Year
- RAPT N/A
- MGF N/A
- P/E Ratio
- RAPT N/A
- MGF N/A
- Revenue Growth
- RAPT N/A
- MGF N/A
- 52 Week Low
- RAPT $5.67
- MGF $2.91
- 52 Week High
- RAPT $30.60
- MGF $3.46
- Technical
- Relative Strength Index (RSI)
- RAPT 43.57
- MGF 48.66
- Support Level
- RAPT $6.88
- MGF $3.05
- Resistance Level
- RAPT $8.91
- MGF $3.09
- Average True Range (ATR)
- RAPT 0.70
- MGF 0.03
- MACD
- RAPT -0.16
- MGF 0.00
- Stochastic Oscillator
- RAPT 11.36
- MGF 55.56
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About MGF MFS Government Markets Income Trust
MFS Government Markets Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income. The fund invests a majority of the net assets, including borrowings for investment purposes, in U.S. and foreign government securities. The company invest various sectors like U.S. Treasury Securities, Mortgage-Backed Securities, Investment Grade Corporates, Municipal Bonds, Non-U.S. Government Bonds, etc, out of which maximum revenue is gained from U.S. Treasury Securities.